Back to Dividend Stocks
United Therapeutics Corporation (UTHR) logo

United Therapeutics Corporation

S&P 500

UTHR/Healthcare · Drug Manufacturers - Specialty & Generic/NASDAQ

Stock Price

$543.39

Stock Price$543.39P/E19.8MCap22.8BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

UTHR does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About United Therapeutics Corporation

United Therapeutics Corporation is a biotechnology company specializing in therapies for pulmonary arterial hypertension (PAH), pulmonary hypertension associated with interstitial lung disease, and other serious conditions. Founded in 1996 and headquartered in Silver Spring, Maryland, the company operates as a public benefit corporation focused on developing innovative treatments and technologies. Its FDA-approved therapeutic portfolio includes Tyvaso (treprostinil), available in both inhalation powder and nebulized formulations; Remodulin Injection; Orenitram Extended-Release Tablets; Adcirca (tadalafil); and Unituxin for treating PAH and related conditions. Beyond traditional pharmaceuticals, United Therapeutics pursues transformational initiatives through its subsidiary Lung Biotechnology PBC to address the critical shortage of transplantable organs through xenotransplantation and bioengineering technologies. The company maintains a robust commercial presence, distributing products through healthcare provider networks and partnerships. Its pipeline includes clinical programs exploring new therapeutic indications, delivery mechanisms, and organ manufacturing solutions. United Therapeutics serves patients, healthcare providers, and research institutions globally, combining steady commercial performance with visionary medical innovation.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$272.12 - $609.35

Earnings & Profitability

UTHR earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

Next Payment Date

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

UTHR Dividend Calculator

Total Investment

$54,339.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is UTHR's current dividend yield?
United Therapeutics Corporation (UTHR) currently has a dividend yield of 0.00%, based on a stock price of $543.39 and an annual dividend of $0.00.
When is UTHR's next dividend payment date?
UTHR's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does UTHR pay in dividends per year?
United Therapeutics Corporation pays dividends unknown. Annual dividend data is not yet available.
Has UTHR been increasing its dividend?
United Therapeutics Corporation has grown its dividend at a 5-year CAGR of —.
Is UTHR's dividend safe?
United Therapeutics Corporation has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is UTHR's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates United Therapeutics Corporation's dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track UTHR Dividends with OnlyDividends

What will UTHR actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.